St. Louis Children's Hospital

Valeos Welcomes Dr. Stuart Sweet to Board of Directors

Retrieved on: 
Tuesday, April 9, 2024
American Express, Advisory Committee, Transplant, Organ transplantation, St. Louis Children's Hospital, GM, Information technology, Medicine, Entrepreneurship, CPO, Patient, SVP, CISO, Research, Organ, Human services, Doctor of Philosophy, Lung transplantation, MD, Quality of life, Health policy, Former, Hospital, Author, Ecosystem, OPTN, Government, Pediatrics, Dentistry

WASHINGTON, April 9, 2024 /PRNewswire/ -- Valeos, a 501(c)(3) nonprofit organization designed to improve organ transplant outcomes for patients and organ donors through data collaboration, today announced the appointment of Dr. Stuart C. Sweet, MD, PhD to its Board of Directors. Dr. Sweet is the W. McKim Marriott Professor of Pediatrics at Washington University in St. Louis, MO, and served as the 2016-2017 Board President of the Organ Procurement and Transplantation Network (OPTN), the U.S. national transplant system. Dr. Sweet spent more than two decades as the medical director of the pediatric lung transplant program at Washington University School of Medicine in St. Louis and St. Louis Children's Hospital, focusing clinically on pediatric lung transplantation and gaining expertise in organ allocation, clinical outcomes, health policy and the role of information technology in medicine.

Key Points: 
  • "I am honored to join the exceptional team at Valeos and continue my dedication to advancing the U.S. organ transplant system," said Dr. Sweet.
  • "We're excited to welcome Dr. Sweet to our Board of Directors.
  • This announcement follows an exciting year for Valeos, which saw its first appointments to its Board of Directors and Advisory Committee this past January.
  • With the backing of leading figures in healthcare, technology and government, Valeos is committed to building the world's largest de-identified transplant data sandbox.

World's first pediatric deformity case using immersive augmented reality surgical navigation

Retrieved on: 
Thursday, December 21, 2023
Hospital, FDA, Surgeon, Deformity, Depth perception, Operating, St. Louis Children's Hospital, Spine, Human

SALT LAKE CITY, Dec. 21, 2023 /PRNewswire/ -- Dr. Scott Luhmann, an orthopedic surgeon at Washington University School of Medicine in St. Louis, performed the world's first pediatric deformity case using the VisAR immersive augmented reality surgical navigation.

Key Points: 
  • SALT LAKE CITY, Dec. 21, 2023 /PRNewswire/ -- Dr. Scott Luhmann, an orthopedic surgeon at Washington University School of Medicine in St. Louis, performed the world's first pediatric deformity case using the VisAR immersive augmented reality surgical navigation.
  • Typically, surgeons need to look back and forth from a screen to the patient in order to use navigation software.
  • With VisAR, 3D image datasets are superimposed on the patient's body, enabling the surgeon to look directly at the patient throughout the surgery using an augmented reality headset.
  • For example, in a typical navigation system, if you deflect the spine, there is a lag before the images are re-registered.

Spire Announces Steve Lindsey as President and CEO

Retrieved on: 
Thursday, September 21, 2023
Civic, SR, St. Louis Children's Hospital, Atlanta Gas Light, Georgia Tech, American Gas Association, Natural gas, Southern Company Gas, History, Spire Inc, Commerce, Executive Council, Growth, Hospital, United Master Executive Council, NYSE, NextEra Energy, Management, Spire

ST. LOUIS, Sept. 21, 2023 /PRNewswire/ -- Spire Inc. (NYSE: SR) today announced that, effective October 1, 2023, Steven L. Lindsey has been named its president and chief executive officer and has been appointed to Spire's Board of Directors. Steve, who currently serves as Spire's executive vice president and chief operating officer, will succeed Suzanne Sitherwood who announced earlier this year her intention to retire at the end of December.

Key Points: 
  • Steve, who currently serves as Spire's executive vice president and chief operating officer, will succeed Suzanne Sitherwood who announced earlier this year her intention to retire at the end of December.
  • "After concluding a thoughtful and comprehensive executive search process and considering a number of well-qualified candidates, the Board of Directors is very pleased that Steve Lindsey will take on the role of leading Spire into the future.
  • Steve is an accomplished executive leader, with deep knowledge of the industry and of Spire – and he has a proven history of building high performance teams and delivering results," said Ed Glotzbach, chair of Spire Inc.'s Board of Directors.
  • At Spire, we're focused on delivering affordable, reliable and safe energy to our customers, while delivering value to our shareholders.

Phoenix Children's Promotes Dr. Jared Muenzer to Chief Physician Executive

Retrieved on: 
Tuesday, August 29, 2023
Medical school, Communication, St. Louis Children's Hospital, ER, National Association Medical Staff Services, University, Emergency medicine, Münzer, Phoenix Children's Hospital, Anesthesiology, Pediatrics, Abrazo Arrowhead Campus, PCMG, Business, MBA, Research, Emergency department, Associate, University of Pittsburgh Medical Center, Surgeon, Nephrology, Medical director, MD, Physician, Arizona State University, School, Health, Research institute, Hospital, Phoenix, Pediatrix Medical Group, Nursing, Neonatology, Medicine

PHOENIX, Aug. 29, 2023 /PRNewswire/ -- Phoenix Children's, one of the nation's fastest-growing pediatric healthcare systems, today announced the promotion of Jared Muenzer, MD, MBA, to Chief Physician Executive. Muenzer also will continue to serve as Chief Operating Officer of Phoenix Children's Medical Group, a role he has held since 2016.

Key Points: 
  • Dr. Muenzer to lead clinical care, research and medical education at Phoenix Children's
    PHOENIX, Aug. 29, 2023 /PRNewswire/ -- Phoenix Children's , one of the nation's fastest-growing pediatric healthcare systems, today announced the promotion of Jared Muenzer, MD, MBA , to Chief Physician Executive.
  • Muenzer also will continue to serve as Chief Operating Officer of Phoenix Children's Medical Group, a role he has held since 2016.
  • As Chief Physician Executive, Muenzer will lead all clinical care, including the health system's growing behavioral health services, Phoenix Children's Care Network (PCCN), clinical research efforts at the Phoenix Children's Research Institute, medical education and the growing network of Phoenix Children's Pediatrics practices, which provide comprehensive preventative, primary care services at locations throughout Arizona.
  • "Since joining our health system in 2012, Dr. Muenzer has played a key role in transforming clinical care at Phoenix Children's," said Phoenix Children's President and CEO Robert L. Meyer.

Nancy J. Mendelsohn, MD, FACMG, Accomplished Healthcare Leader and Medical Geneticist, is Elected President of the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Thursday, March 16, 2023
Research, Genetic distance, Health, Children's Hospital, Division, University of Minnesota Medical School, UnitedHealth Group, Education, Genetic, ACMG, Hospital, Molecular biology, Medicine, Hennepin County Medical Center, Genetics, American College of Medical Genetics and Genomics, Believer, St. Louis Children's Hospital, American Academy, Pediatrics, American College, Glycogen storage disease, FACMG, DMC-College Foundation, Gillette Children's Specialty Healthcare, University, Pediatrics (journal), AAP, Knowledge, Optum, Washington University in St. Louis, American Board of Commissioners for Foreign Missions, Doctor of Philosophy, Medical genetics, Nursing, Child, MD, College, Genomics, Indiana University, Science

BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.

Key Points: 
  • BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.
  • The ACMG Foundation is a national nonprofit foundation dedicated to improving health and patient care through the support of research, education and the safe, effective practice of genetic and genomic medicine.
  • "I am delighted that Dr. Nancy Mendelsohn will succeed me as president of the ACMG Foundation.
  • Dr. Mendelsohn is an accomplished medical geneticist with broad experience both in clinical practice and the administration and management of medical genetics services.

Purina and St. Louis Blues Unveil 'Purina Doghouse' Penalty Box For 2022-2023 Season

Retrieved on: 
Thursday, October 13, 2022
Veterinarian, Community development, Brand, Marketing, Purina One, Hospital, Friskies PetCare Company, St. Louis Blues, Organization, Hockey, Patient, Health, Barclay, Dog, PETS, Mental health, Program, Multimedia, Partnership, Behavior, St. Louis Children's Hospital, NHL, Awareness, Fancy Feast, Environment, Nestlé Purina PetCare, Enterprise Center, 2018–19 St. Louis Blues season, Wellness, Ice, View, Cat, Pharmaceutical industry, Medicine, Bottled water, St. Louis, Blues, Purina

ST. LOUIS, Oct. 13, 2022 /PRNewswire/ -- Ahead of the start of the 2022-2023 NHL regular season, the St. Louis Blues Hockey Club today unveiled the Purina Doghouse, a new moniker for the away team's penalty box at Enterprise Center in downtown St. Louis. Visits to the Purina Doghouse, which signifies Blues opponents taking a penalty, will trigger a $100 donation each time a player visits the away team penalty box from Purina, up to $15,000 to local service and support dog training organizations.

Key Points: 
  • Visits to the Purina Doghouse, which signifies Blues opponents taking a penalty, will trigger a $100 donation each time a player visits the away team penalty box from Purina, up to $15,000 to local service and support dog training organizations.
  • "The Purina Doghouse represents a unique opportunity to help engage fans with tips to help their pets at home.
  • Barclay, the Blues official Duo Dogs Ambassador, who is fueled by Purina Pro Plan, will play a key role in the Purina Doghouse educational elements provided by Purina experts throughout the course of the season.
  • Nestl Purina PetCare Company was founded in St. Louis in 1894 and employs more than 2,000 associates at its downtown St. Louis headquarters.

Medtronic receives FDA clearance for expanded indication of LINQ II™ insertable cardiac monitor for use in pediatric patients ages 2 and older

Retrieved on: 
Tuesday, September 20, 2022
Asystole, Dizziness, Health, Algorithm, Swimming, Chest pain, LINQ, NYSE, Twitter, FDA, Food, Hospital, Cardiac electrophysiology, Washington University in St. Louis, LinkedIn, MRI, Syncope, ICM, Bluetooth, U.S. Securities and Exchange Commission, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Patient, Physician, AAA, Pain, St. Louis Children's Hospital, Palpitations, Solution, Magnetic resonance imaging, Artificial intelligence, Atrial fibrillation, Caregiver, Katherine Seley-Radtke, Cardiology, AF, Heart, Security (finance), Parent, Conference, Communication, Veni, vidi, vici, Medical device, Medtronic

DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the LINQ II™ Insertable Cardiac Monitor (ICM) system is the first-and-only ICM to receive 510(k) clearance by the U.S. Food and Drug Administration (FDA) for use in pediatric patients over the age of 2 who have heart rhythm abnormalities and require long-term, continuous monitoring.

Key Points: 
  • "The data generated from these small monitors can help us better tailor treatment decisions and ongoing management for our patients."
  • The latest-generation device has been implanted in thousands of patients globally since it was first commercialized in 2020.
  • Medtronic has been a pioneer in the development of insertable cardiac monitors for more than 20 years; to date, more than 1.7 million patients have received a Medtronic ICM.6
    Bold thinking.
  • Innovative Artificial Intelligence Application Reduces False Pause Alerts while Maintaining Perfect Trye Pause Sensitivity for Insertable Cardiac Monitors.

CapStone Holdings Inc. and Gamers Outreach Bring Gaming to Children's Hospitals in St. Louis

Retrieved on: 
Thursday, September 15, 2022
SSM, St. Louis Children's Hospital, Software, GO, Rock (geology), U.S. News & World Report, Child, Risk, Major League Baseball, Hospital, Recreation, News, Go-kart, Washington University School of Medicine, Patient, Digestive system surgery, Cardinal, Gamers Outreach Foundation, Student, Gastroenterology, Child life specialist, Electric go-kart, STEM, Gamer, Children's Hospital, Video, Music, Research, Medicine, Multimedia, View, Nephrology, Video game, St. Louis, Neonatology

ST. LOUIS, Sept. 15, 2022 /PRNewswire/ -- CapStone Holdings Inc. ("CapStone Holdings") partnered with Michigan-based non-profit organization Gamers Outreach to gift gaming carts (GO Karts -- portable gaming kiosks) to St. Louis Children's Hospital and SSM Health Cardinal Glennon Children's Hospital. Each hospital received four GO Karts with the intent to offer a form of recreation to kids and young adults in inpatient care.

Key Points: 
  • Eight portable gaming units were donated to St. Louis Children's Hospital and Cardinal
    ST. LOUIS, Sept. 15, 2022 /PRNewswire/ -- CapStone Holdings Inc. ("CapStone Holdings") partnered with Michigan-based non-profit organization Gamers Outreach to gift gaming carts (GO Karts -- portable gaming kiosks) to St. Louis Children's Hospital and SSM Health Cardinal Glennon Children's Hospital.
  • We are so grateful for this donation from CapStone Holdings and Gamers Outreach.
  • Gamers Outreach has since delivered kiosks to more than 360 hospitals worldwide servicing as many as 4 million patients each year.
  • Through equipment and software, Gamers Outreach is helping kids in hospitals gain access to activities and do what kids do best - be themselves.

Parent Project Muscular Dystrophy Announces Pediatric Certified Duchenne Care Center at St. Louis Children's Hospital

Retrieved on: 
Thursday, July 7, 2022
People, Review, Health, FDA, APRN, U.S. News & World Report, View, Patient, Duchenne muscular dystrophy, Dystrophinopathy, Research, Single person, St. Louis Children's Hospital, BJC HealthCare, Population, Growth, Washington University in St. Louis, Degenerative disease, Multimedia, Disease, History, Muscle, Washington University School of Medicine, PPMD, Neurology, Certification, Hospital, YouTube, News, Instagram, Family, BJC, Twitter, Education, Program, CDC, Medicine, Child, Becker, St. Louis, Duchenne, Facebook

WASHINGTON, July 7, 2022 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced the expansion of their renowned Certified Duchenne Care Center Program (CDCCP) with the certification of the clinic at St. Louis Children's Hospital. This is an exciting step for the CDCCP as it continues to expand its reach to include St. Louis and the surrounding region.

Key Points: 
  • Leading Duchenne Organization Expands Certification of Clinics that Provide Optimal Care for People with Duchenne Muscular Dystrophy with 1st Clinic in St. Louis
    WASHINGTON, July 7, 2022 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD) , a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne) , announced the expansion of their renowned Certified Duchenne Care Center Program (CDCCP) with the certification of the clinic at St. Louis Children's Hospital .
  • "Being the only pediatric certified Duchenne care centerin the St. Louis area is a tribute to the group of professionals who work at our clinic each day," said Zaidman.
  • PPMD's Certified Duchenne Care Center Program supports standardized, comprehensive care and services for all people living with Duchenne.
  • As part of its ongoing mission to end Duchenne, PPMD continues to insist all people with Duchenne receive comprehensive care.

Dr. Terrie Inder, a leading neonatologist and child neurologist, named to new position of chair of Center of Neonatal Research at CHOC

Retrieved on: 
Wednesday, June 8, 2022
Cerebral palsy, Intellectual, Nicu Ceaușescu, Brigham and Women's Hospital, University of California, Irvine, Leadership, Infant, Washington University School of Medicine, Cone Health Women's Hospital, Adult, Time, Royal Women's Hospital, Research, Woman, Harvard Medical School, Neonatology, Child, State government, Mentorship, Disability in Canada, Ventricular septal defect, UC, Center, Investment, Multimedia, National Institutes of Health, CHOC, Research institute, Mission Viejo, California, Growth, Bed, Injury, National, UCI, Murdoch Children's Research Institute, Health, George Washington University School of Medicine & Health Sciences, Hospital, Magnetic resonance imaging, Neurology, MRI, Children's Hospital of Orange County, NICU, St. Louis Children's Hospital, Medicine, Brigham

Her appointment highlights CHOC's mission to advance research and clinical outcomes for children and families, said Dr. Vijay Dhar, division chief of neonatology for CHOC Specialists.

Key Points: 
  • Her appointment highlights CHOC's mission to advance research and clinical outcomes for children and families, said Dr. Vijay Dhar, division chief of neonatology for CHOC Specialists.
  • "Together, we will make CHOC the leading destination for neonatal- perinatal care, research and training."
  • The Center of Neonatal Research at CHOC will advance scientific studies and improve clinical outcomes in the field of neonatal-perinatal medicine.
  • The novel imaging center required cooperation across multiple departments, research institutes and with the regional and state government.